Reducing Activities: company scaling back some business operations while continuing others

Wait Scaling Back

Reducing Activities: company scaling back some business operations while continuing others

Wait Scaling Back
Revenue(RF), mln.USD
261
Staff
995
Capital, mln.USD
218
Glob.Revenue, mln.USD
48700
The Company Statement

Merck to continue supplying essential medicines and vaccines in Russia and will donate any profit from Russia to humanitarian causes, the company will not make further investments in Russia, This includes stopping all promotional activities, capital investments and business development initiatives, Additionally, screening and enrollment in ongoing clinical trials, and planning for new studies in Russia have been suspended,

All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.